Literature DB >> 21223459

Introductory insights into patient preferences for outpatient rehabilitation after knee replacement: implications for practice and future research.

Justine M Naylor1, Rajat Mittal, Katherine Carroll, Ian A Harris.   

Abstract

OBJECTIVES: Current perspectives concerning clinical decision making favour inclusion of patient preference for therapy. This exploratory study aimed to forge introductory insights into patient preference for outpatient-based rehabilitation after total knee replacement (TKR).
METHODS: TKR recipients from six public hospitals participating in a prospective, longitudinal study assessing outcomes after surgery were surveyed 1 year after surgery about preferences for rehabilitation. Surveys were conducted face-to-face or via postal questionnaire. Questions included global satisfaction (percentage scale) with therapy received, future preference for therapy and the reasons underpinning preference.
RESULTS: Ninety-three (93/115) TKR recipients participated [mean age 68 (SD 8) years; 66% female; 75% face-to-face interview]. Group-based (39/93) and one-to-one therapies (38/93) were the most common modes experienced. Most participants (81/93) were highly satisfied (satisfaction ≥ 75%). Future preference was associated with satisfaction with past exposure regardless of mode (P = 0.02), hence no overall preference for one mode emerged. Commonality existed in the reasons why patients preferred specific modes. The most common reason for preferring group-based therapy was psychosocial benefit whilst the more personalized approach was the most common reason for preferring one-to-one therapy.
CONCLUSIONS: Patient global satisfaction is similarly high across different modes of outpatient rehabilitation despite differences in perceived benefits. The association between satisfaction and preference potentially indicates that provided the service is deemed high quality, the actual mode of therapy offered is less important to this patient population. Research is required, however, to establish the relationship between preference and outcome, the stability of preference across time, and the effect of multiple rehabilitation exposures on preference. For now, the quality of current uni-modal programmes could be enhanced by incorporation of features typically associated with alternative modes.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21223459     DOI: 10.1111/j.1365-2753.2010.01619.x

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  5 in total

1.  What is the effect of supervised rehabilitation regime vs. self-management instruction following unicompartmental knee arthroplasty? - a pilot study in two cohorts.

Authors:  Adam Omari; Lina Holm Ingelsrud; Thomas Quaade Bandholm; Susanne Irene Lentz; Anders Troelsen; Kirill Gromov
Journal:  J Exp Orthop       Date:  2021-06-09

2.  Understanding consumer and clinician preferences and decision making for rehabilitation following arthroplasty in the private sector.

Authors:  Mark A Buhagiar; Justine M Naylor; Grahame Simpson; Ian A Harris; Friedbert Kohler
Journal:  BMC Health Serv Res       Date:  2017-06-19       Impact factor: 2.655

3.  Factors affecting patient participation in orthopaedic trials comparing surgery to non-surgical interventions.

Authors:  Rajat Mittal; Ian A Harris; Sam Adie; Justine M Naylor
Journal:  Contemp Clin Trials Commun       Date:  2016-05-13

4.  Patient preferences for emergency or planned hip fracture surgery: a cross-sectional study.

Authors:  Abhinav Aggarwal; Ian A Harris; Justine M Naylor
Journal:  J Orthop Surg Res       Date:  2016-10-17       Impact factor: 2.359

5.  Comparison of group-based outpatient physiotherapy with usual care after total knee replacement: a feasibility study for a randomized controlled trial.

Authors:  Neil Artz; Samantha Dixon; Vikki Wylde; Elsa Marques; Andrew D Beswick; Erik Lenguerrand; Ashley W Blom; Rachael Gooberman-Hill
Journal:  Clin Rehabil       Date:  2016-07-10       Impact factor: 3.477

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.